Adults with moderate overweight (BMI of 27 or greater) with at least one weight-related condition, such as type 2 diabetes, high cholesterol, or high blood pressure (hypertension)
(92) found that S
Ozempic, Mounjaro manufacturers sued over claims of "stomach paralysis" side effects A personal injury law firm has filed a lawsuit against Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro, over claims that the diabetes drugs, which are popular for aiding weight loss, can cause gastroparesis, a paralysis of the stomach
The safety profile remains remarkably clean with minimal side effects reported across decades of use
Despite the FDAs warning against using off-brand semaglutide compounds due to their potential adverse effects, a shortage of brand-name drugs and their hefty $1,300-a-month price tag is motivating people to seek cheaper, more accessible options
Sokolova A, Patel S, Akella J